6 hours Ago Soleno Therapeutics ( NASDAQ: SLNO ) on Tuesday said it has entered into a loan and security agreement with Oxford Finance and its affiliates for up to $200 million. Under the terms of the agreement with Oxford, Soleno drew an initial $50 million at closing.
